Executive Summary
Today's insider tape is dominated by a broad wave of equity awards and option grants (Spruce Power, Jaguar Uranium, Regis, Ventas, FuelCell, Shutterstock, Omeros, D-Wave, Capstone, Gain Therapeutics, Actuate) that signal board-level compensation activity rather than open-market conviction.
Against that neutral backdrop, the most actionable signals are a cluster of discretionary and 10b5-1 sales: Delta CEO Ed Bastian sold 50,000 shares (~$4.1M), Porch Group saw its CFO and a director sell ~$1.05M combined, CoreWeave's PAO sold ~$392K post-option exercise, and Carnival, Impinj, Zoom, PagerDuty, ACADIA, Trupanion, Landmark, Bridgewater and New ERA insiders all trimmed. The standout bullish datapoint is Rapport Therapeutics director James Healy's ~$20M open-market purchase at $21.00, a rare high-conviction buy in a tape otherwise skewed to sales. Rivian CFO Claire McDonough's disposal of 730,292 shares to the issuer (leaving only 88,886 held) is a material ownership reduction worth flagging. Saba Capital continues its activist-style accumulation in closed-end funds (Gabelli Healthcare, Ellsworth Growth & Income) while trimming BlackRock ESG Term Trust, and Robinhood Markets sold ~$3.08M of Robinhood Ventures Fund I shares.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior Insider Trading Pulse digest from October 23, 2026.
Investment Signals (12)
- Rapport Therapeutics (RAPP) (BULLISH)▲
Director James Healy bought 952,380 shares at $21.00 (~$20M) plus 6,395 and 3,772 share lots at the same price across 4 transactions — the largest open-market insider purchase in today's tape and a strong conviction signal
- Delta Air Lines (DAL)▲
CEO Ed Bastian sold 50,000 shares at $82.00 (~$4.1M) while still holding 1,313,448 shares; the sale is meaningful in dollar terms but represents a modest fraction of his stake, consistent with diversification rather than loss of confidence [NEUTRAL/BEARISH]
- Porch Group (PRCH) (BEARISH)▲
CFO Shawn Tabak sold 30,000 shares at $21.02 (~$631K) under a 10b5-1 plan and director Sean Kell sold 20,784 shares at ~$20.00–$20.30 (~$419K) — two insiders selling into the same ~$20–21 price zone suggests a perceived near-term valuation ceiling
- CoreWeave (CRWV) (BEARISH)▲
Principal Accounting Officer Jeff Baker exercised/converted 12,500 Class A shares and sold 6,412 at $61.14 (~$392K) plus 258 at $61.69, leaving 14,170 shares — a post-exercise sale that reduces his direct exposure by roughly a third
- Rivian (RIVN) (BEARISH)▲
CFO Claire McDonough disposed of 730,292 Class A shares to the issuer, leaving only 88,886 shares — a ~89% reduction in her reported holding and a notable governance/retention datapoint to monitor
- Jaguar Uranium (JAGU)▲
Six insiders (CEO Steven Gold 400,000; CFO Keith Avery 200,000; Executive Chairman Luis Ducassi 125,000; directors Leclerc, Meiklejohn, De Pablos Souza, Fisher Trumbull 100,000 each) received option grants totaling ~1.125M shares — a coordinated board refresh that aligns management with the uranium theme [BULLISH/NEUTRAL]
- Omeros (OMER) (BULLISH)▲
Chairman/CEO Gregory Demopulos received 500,000 performance stock options — performance-contingent awards of this size typically accompany milestone-based compensation tied to pipeline catalysts
- Spruce Power (SPRU) (NEUTRAL)▲
CFO Thomas Cimino (76,100 shares) and directors John Miller and Shawn Kravetz (70,093 each) received stock awards — routine board/officer compensation but confirms continued insider alignment
- Regis Corp (RGS) ↓ (NEUTRAL)▲
Four insiders (CFO Kersten Zupfer, COO Jim Lain, EVP James Suarez, directors Michael Mansbach and William Charters) received awards totaling ~37,000 shares — broad-based grant activity across the executive team
- Saba Capital Management (NEUTRAL)▲
Bought 5,975 Ellsworth Growth & Income shares at $11.87 (~$70.9K) and 500 Gabelli Healthcare shares at $10.09 (~$5.05K) while selling 42,966 BlackRock ESG Term Trust shares at $13.67 (~$587K) — active rotation within closed-end fund discount arbitrage
- ACADIA Pharmaceuticals (ACAD) (NEUTRAL)▲
CFO Mark Schneyer was awarded 6,815 shares and sold 3,321 at $20.88 (~$69.3K), leaving 71,322 shares — a routine net-settlement sale following vesting rather than a discretionary bearish signal
- Vale (VALE)▲
Accounting Officer Elaine de Souza Funo made small open-market purchases (240 shares at $12.55; 7 shares at $11.74) — token buying but directionally positive insider sentiment at a low price point [BULLISH/NEUTRAL]
Risk Flags (10)
- Rivian (RIVN) [HIGH RISK]▼
CFO disposed of 730,292 Class A shares to the issuer, leaving only 88,886 shares (~89% reduction) — raises questions about executive retention and near-term alignment
- Porch Group (PRCH) [MEDIUM RISK]▼
CFO and a director sold ~$1.05M combined within the same ~$20–21 price band; clustered insider sales at a common level often precede consolidation
- CoreWeave (CRWV) [MEDIUM RISK]▼
PAO sold ~$392K immediately after exercising 12,500 options, reducing direct holdings to 14,170 shares — post-exercise selling can signal limited near-term upside conviction
- Delta Air Lines (DAL) [MEDIUM RISK]▼
CEO sold $4.1M at $82.00; while a small fraction of his 1.31M-share stake, large-dollar CEO sales at cyclical highs warrant monitoring for follow-on sales
- Blue Biofuels (BLBL) [HIGH RISK]▼
Director Chris Kneppers sold 452,000 shares across three lots at $0.10–$0.11 (~$47K) — micro-cap insider selling at sub-penny-adjacent prices signals limited confidence
- New ERA Energy & Digital (NEE) [MEDIUM RISK]▼
Director Trent Yang was awarded 259,548 shares, sold 49,397 at $1.99 (~$98K) and gifted 2,000 — award-then-sell pattern in a sub-$2 stock is a caution flag
- Robinhood Ventures Fund I↓ [MEDIUM RISK]▼
10% owner Robinhood Markets sold 124,319 shares at $24.77 (~$3.08M) — sponsor-level selling of a fund vehicle can pressure the discount/premium dynamics
- Zoom Communications (ZM)▼
Director Santiago Subotovsky sold 1,442 shares at $100.14 (~$144K) under a 10b5-1 plan — small but part of a persistent director-selling pattern near the $100 level [LOW/MEDIUM RISK]
- Impinj (PI)▼
Director Meera Rao sold 1,729 shares at $201.60 (~$349K) under a 10b5-1 plan — high-priced stock insider trimming warrants attention to valuation [LOW/MEDIUM RISK]
- HAIN Celestial (HAIN) [HIGH RISK]▼
Two executives (President International Wolfgang Goldenitsch and CFO Lee Boyce) had shares withheld for taxes at $0.13 following RSU conversions — the $0.13 reference price implies severe prior price depreciation and is a red flag on the equity story
Opportunities (10)
- Rapport Therapeutics (RAPP) (OPPORTUNITY)◆
Director's ~$20M open-market purchase at $21.00 is a rare high-conviction signal; historically, director buys of this magnitude precede positive clinical or strategic catalysts
- Jaguar Uranium (JAGU) (OPPORTUNITY)◆
Coordinated option grants to six insiders (~1.125M shares) align management with uranium price upside; watch for vesting schedules and any open-market follow-through
- Omeros (OMER) (OPPORTUNITY)◆
500,000 performance stock options to the CEO tie compensation to milestones — a structure that often precedes pipeline readouts or partnership announcements
- Saba Capital CEF Rotation (OPPORTUNITY)◆
Saba is buying Ellsworth Growth & Income at $11.87 and Gabelli Healthcare at $10.09 while selling BlackRock ESG Term Trust at $13.67 — tracking Saba's discount-arbitrage flow can identify CEFs trading at wide discounts
- Vale (VALE) (OPPORTUNITY)◆
Small insider purchases at $11.74–$12.55 suggest a perceived floor near current levels; monitor for additional buying that would confirm a bottoming thesis
- Spruce Power (SPRU) (OPPORTUNITY)◆
CFO and two directors received ~216K shares combined — continued insider alignment in a small-cap renewable energy name; watch for any open-market buying to confirm conviction
- Regis Corp (RGS)↓ (OPPORTUNITY)◆
Broad-based awards to CFO, COO and directors (~37K shares) suggest board confidence in the turnaround; monitor for any subsequent open-market purchases
- D-Wave Quantum (QBTS)↓ (OPPORTUNITY)◆
Director Kevan Krysler received 15,054 shares — initial grant to a new director; watch for any follow-on open-market buying as a signal of conviction in the quantum computing theme
- Capstone Green Energy (CGRN) (OPPORTUNITY)◆
Director Brandon Schwertner received 8,138 voting common shares — small but notable alignment in a micro-cap energy name
- FuelCell Energy (FCEL) (OPPORTUNITY)◆
Director Peter Hopper received 2,231 restricted stock units — routine but confirms continued board engagement in the hydrogen theme
Sector Themes (6)
- Compensation-Driven Insider Flow Dominates◆
20+ of today's 50 filings are equity awards or option grants (Spruce Power, Jaguar Uranium, Regis, Ventas, FuelCell, Shutterstock, Omeros, D-Wave, Capstone, Gain Therapeutics, Actuate) — the tape reflects routine compensation rather than discretionary conviction, so open-market buys/sells deserve outsized weight
- Biotech/Pharma Insider Buying Stands Out◆
Rapport's ~$20M director buy and Omeros' 500K performance options contrast with sales at ACADIA and Gain Therapeutics — selective conviction in clinical-stage names while others trim
- Consumer/Industrial Insiders Trimming at Cyclical Highs◆
Delta CEO ($4.1M), Carnival director ($694K), Impinj director ($349K) and Zoom director ($144K) all sold near elevated prices — a pattern of profit-taking in cyclical and high-multiple names
- Micro-Cap and Distressed Insiders Selling◆
Blue Biofuels ($0.10–$0.11), New ERA ($1.99) and HAIN ($0.13 tax withholding reference) show insider selling or distressed pricing in small-cap names — a warning on liquidity and equity value in the lower tiers
- Activist CEF Rotation by Saba Capital◆
Saba's buys in Ellsworth and Gabelli Healthcare versus its BlackRock ESG Term Trust sale highlight active discount-arbitrage rotation within closed-end funds — a niche but trackable flow signal
- Uranium and Quantum Thematic Grants◆
Jaguar Uranium's six-insider option package and D-Wave's new director grant reflect board-level positioning in uranium and quantum computing — thematic alignment worth monitoring for follow-on open-market activity
Watch List (8)
- Rapport Therapeutics (RAPP)👁
Monitor for follow-on insider buying after the ~$20M director purchase; any additional open-market buys would reinforce the conviction signal
- Rivian (RIVN)👁
Watch for 8-K or Form 4 follow-ups explaining the CFO's 730,292-share disposal to the issuer and any retention/severance disclosures
- Porch Group (PRCH)👁
Track whether additional insiders sell in the $20–21 zone; clustered sales often precede a consolidation or guidance update
- Delta Air Lines (DAL)👁
Monitor for additional CEO sales or 10b5-1 plan amendments following the $4.1M sale at $82.00
- Jaguar Uranium (JAGU)👁
Watch for vesting schedules and any open-market purchases by the six insiders who received ~1.125M options
- CoreWeave (CRWV)👁
Track post-exercise selling patterns by the PAO and other officers; continued sales could pressure sentiment around the AI infrastructure name
- Saba Capital CEF Positions👁
Monitor 13D/13G amendments and further buys/sells in Ellsworth, Gabelli Healthcare and BlackRock ESG Term Trust for discount-arbitrage signals
- HAIN Celestial (HAIN)👁
The $0.13 tax-withholding reference price implies severe equity depreciation — watch for any restructuring, delisting or reverse-split announcements
Filing Analyses
(50)
30-10-2026
Chief Financial Officer Cimino Thomas James was awarded 76,100 Common Stock. Cimino Thomas James holds 136,100 shares after the transaction.
- · Chief Financial Officer Cimino Thomas James was awarded 76,100 Common Stock
30-10-2026
Director Rao Meera sold 1,729 Common Stock at $201.60 (~$349K). Rao Meera holds 9,593 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Rao Meera sold 1,729 Common Stock at $201.60 (~$349K)
30-10-2026
EVP Ch. Prod. & Tech Officer Dianaty Ali had withheld for taxes 449 Common Stock at $18.93 (~$8.5K). Dianaty Ali holds 325,817 shares after the transaction.
- · EVP Ch. Prod. & Tech Officer Dianaty Ali had withheld for taxes 449 Common Stock at $18.93 (~$8.5K)
30-10-2026
Director Krysler P. Kevan was awarded 15,054 Common Stock, par value $0.0001 per share ("Common Stock"). Krysler P. Kevan holds 15,054 shares after the transaction.
- · Director Krysler P. Kevan was awarded 15,054 Common Stock, par value $0.0001 per share ("Common Stock")
30-10-2026
See Remarks Weidner Jeanette was awarded 130,000 Stock Option (right to buy).
- · See Remarks Weidner Jeanette was awarded 130,000 Stock Option (right to buy)
30-10-2026
Director Leclerc Maxime Henri Alexandre was awarded 100,000 Stock Option (right to buy).
- · Director Leclerc Maxime Henri Alexandre was awarded 100,000 Stock Option (right to buy)
30-10-2026
Director Meiklejohn Janet Lee was awarded 100,000 Stock Option (right to buy).
- · Director Meiklejohn Janet Lee was awarded 100,000 Stock Option (right to buy)
30-10-2026
Executive Chairman Ducassi Luis Augusto was awarded 125,000 Stock Option (right to buy).
- · Executive Chairman Ducassi Luis Augusto was awarded 125,000 Stock Option (right to buy)
30-10-2026
Chief Financial Officer Avery William Edward Keith was awarded 200,000 Stock Option (right to buy).
- · Chief Financial Officer Avery William Edward Keith was awarded 200,000 Stock Option (right to buy)
30-10-2026
Chairman, CEO & President Demopulos Gregory A MD was awarded 500,000 Performance Stock Option (right to buy).
- · Chairman, CEO & President Demopulos Gregory A MD was awarded 500,000 Performance Stock Option (right to buy)
30-10-2026
Director De Pablos Souza Tomas was awarded 100,000 Stock Option (right to buy).
- · Director De Pablos Souza Tomas was awarded 100,000 Stock Option (right to buy)
30-10-2026
Director Subotovsky Santiago sold 1,442 Class A Common Stock at $100.14 (~$144K). Subotovsky Santiago holds 116,512 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Subotovsky Santiago sold 1,442 Class A Common Stock at $100.14 (~$144K)
30-10-2026
Director Fisher Trumbull Grant was awarded 100,000 Stock Option (right to buy).
- · Director Fisher Trumbull Grant was awarded 100,000 Stock Option (right to buy)
30-10-2026
President, CEO, and Director Gold Steven Brian was awarded 400,000 Stock Option (right to buy).
- · President, CEO, and Director Gold Steven Brian was awarded 400,000 Stock Option (right to buy)
30-10-2026
Director BIOS Fund III, LP was awarded 64,995 Warrant (Right to Buy). 13 transactions reported in total.
- · Director BIOS Fund III, LP was awarded 64,995 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 87,743 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 682,885 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 194,984 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 368,304 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 47,972 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 82,018 Warrant (Right to Buy)
- · Director BIOS Fund III, LP was awarded 36,056 Warrant (Right to Buy)
30-10-2026
Chief Executive Officer Bastian Edward H sold 50,000 Common Stock at $82.00 (~$4.1M). Bastian Edward H holds 1,313,448 shares after the transaction.
- · Chief Executive Officer Bastian Edward H sold 50,000 Common Stock at $82.00 (~$4.1M)
30-10-2026
President Sanders Dax gifted 1,600 Class P Common Stock. Sanders Dax holds 367,871 shares after the transaction.
- · President Sanders Dax gifted 1,600 Class P Common Stock
30-10-2026
Director Kneppers Chris J sold 250,000 Common Stock at $0.10 (~$25K). Kneppers Chris J holds 19,295,167 shares after the transaction.
- · Director Kneppers Chris J sold 250,000 Common Stock at $0.10 (~$25K)
- · Director Kneppers Chris J sold 152,000 Common Stock at $0.11 (~$16.7K)
- · Director Kneppers Chris J sold 50,000 Common Stock at $0.11 (~$5.5K)
30-10-2026
10% owner Robinhood Markets, Inc. sold 124,319 Common Shares of Beneficial Interest at $24.77 (~$3.08M). Robinhood Markets, Inc. holds 12,921,815 shares after the transaction.
- · 10% owner Robinhood Markets, Inc. sold 124,319 Common Shares of Beneficial Interest at $24.77 (~$3.08M)
30-10-2026
Principal Accounting Officer Baker Jeff sold 6,412 Class A Common Stock at $61.14 (~$392K). 4 transactions reported in total. Baker Jeff holds 14,170 shares after the transaction.
- · Principal Accounting Officer Baker Jeff exercised/converted 12,500 Class A Common Stock
- · Principal Accounting Officer Baker Jeff sold 258 Class A Common Stock at $61.69 (~$15.9K)
- · Principal Accounting Officer Baker Jeff sold 6,412 Class A Common Stock at $61.14 (~$392K)
- · Principal Accounting Officer Baker Jeff exercised/converted 12,500 Restricted Stock Units
30-10-2026
Director Kell Sean Davis sold 10,500 Common Stock at $20.00 (~$210K). Kell Sean Davis holds 292,863 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Kell Sean Davis sold 10,500 Common Stock at $20.00 (~$210K)
- · Director Kell Sean Davis sold 10,284 Common Stock at $20.30 (~$209K)
30-10-2026
Chief Financial Officer McDonough Claire disposed to the issuer 730,292 Class A Common Stock. McDonough Claire holds 88,886 shares after the transaction.
- · Chief Financial Officer McDonough Claire disposed to the issuer 730,292 Class A Common Stock
30-10-2026
Director Schwertner Brandon Keith was awarded 8,138 Voting Common Stock. Schwertner Brandon Keith holds 8,138 shares after the transaction.
- · Director Schwertner Brandon Keith was awarded 8,138 Voting Common Stock
30-10-2026
Director HEALY JAMES bought 952,380 Common Stock at $21.00 (~$20M). 4 transactions reported in total. HEALY JAMES holds 25,267 shares after the transaction.
- · Director HEALY JAMES bought 952,380 Common Stock at $21.00 (~$20M)
- · Director HEALY JAMES bought 6,395 Common Stock at $21.00 (~$134K)
- · Director HEALY JAMES bought 3,772 Common Stock at $21.00 (~$79.2K)
- · Director HEALY JAMES bought 6,933 Common Stock at $21.00 (~$146K)
30-10-2026
Director Hopper Peter B. was awarded 2,231 Director Restricted Stock Unit.
- · Director Hopper Peter B. was awarded 2,231 Director Restricted Stock Unit
30-10-2026
EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold 3,321 Common Stock at $20.88 (~$69.3K). Schneyer Mark C. holds 71,322 shares after the transaction.
- · EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. was awarded 6,815 Common Stock
- · EVP, CHIEF FINANCIAL OFFICER Schneyer Mark C. sold 3,321 Common Stock at $20.88 (~$69.3K)
30-10-2026
Accounting Officer de Souza Funo Elaine Maria bought 240 Common Shares at $12.55 (~$3.01K). de Souza Funo Elaine Maria holds 32,509 shares after the transaction.
- · Accounting Officer de Souza Funo Elaine Maria bought 240 Common Shares at $12.55 (~$3.01K)
- · Accounting Officer de Souza Funo Elaine Maria bought 7 Common Shares at $11.74 (~$82.2)
30-10-2026
Executive Chair Tejada Jennifer sold 5,945 Common Stock at $18.00 (~$107K). Tejada Jennifer holds 1,431,596 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Executive Chair Tejada Jennifer exercised/converted 3,000 Common Stock at $7.43 (~$22.3K)
- · Executive Chair Tejada Jennifer sold 5,945 Common Stock at $18.00 (~$107K)
- · Executive Chair Tejada Jennifer exercised/converted 3,000 Stock Option (Right to Buy)
30-10-2026
President and COO Assi Hichame was awarded 143,348 Restricted Stock Unit.
- · President and COO Assi Hichame was awarded 143,348 Restricted Stock Unit
30-10-2026
Director LEWIS JIM sold 550 Common Stock at $32.16 (~$17.7K). LEWIS JIM holds 152,732 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director LEWIS JIM sold 26 Common Stock at $32.48 (~$844)
- · Director LEWIS JIM sold 550 Common Stock at $32.16 (~$17.7K)
30-10-2026
10% owner Saba Capital Management, L.P. sold 42,966 Common Stock at $13.67 (~$587K). Saba Capital Management, L.P. holds 12,264,253 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. sold 42,966 Common Stock at $13.67 (~$587K)
30-10-2026
CHIEF FINANCIAL OFFICER Tabak Shawn sold 30,000 Common Stock at $21.02 (~$631K). Tabak Shawn holds 176,059 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CHIEF FINANCIAL OFFICER Tabak Shawn sold 30,000 Common Stock at $21.02 (~$631K)
30-10-2026
Director Miller John P. was awarded 70,093 Common Stock. Miller John P. holds 273,919 shares after the transaction.
- · Director Miller John P. was awarded 70,093 Common Stock
30-10-2026
Director Kravetz Shawn W was awarded 70,093 Common Stock. Kravetz Shawn W holds 265,593 shares after the transaction.
- · Director Kravetz Shawn W was awarded 70,093 Common Stock
30-10-2026
Director Deeble Helen sold 25,000 Common Shares at $27.75 (~$694K). Deeble Helen holds 63,504.685 shares after the transaction.
- · Director Deeble Helen sold 25,000 Common Shares at $27.75 (~$694K)
30-10-2026
10% owner Sinensky Michael gifted 3,000,000 Common Stock. Sinensky Michael holds 12,323,718 shares after the transaction.
- · 10% owner Sinensky Michael gifted 3,000,000 Common Stock
30-10-2026
10% owner Saba Capital Management, L.P. bought 500 Common Stock at $10.09 (~$5.05K). Saba Capital Management, L.P. holds 2,174,625 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 500 Common Stock at $10.09 (~$5.05K)
30-10-2026
Director Yang Trent sold 49,397 Common Stock at $1.99 (~$98.4K). 4 transactions reported in total. Yang Trent holds 249,701 shares after the transaction.
- · Director Yang Trent was awarded 259,548 Common Stock
- · Director Yang Trent sold 49,397 Common Stock at $1.99 (~$98.4K)
- · Director Yang Trent gifted 2,000 Common Stock
- · Director Yang Trent was awarded 41,550 Common Stock
30-10-2026
Director MANSBACH MICHAEL JOSEPH was awarded 2,857 Common Stock. MANSBACH MICHAEL JOSEPH holds 10,971 shares after the transaction.
- · Director MANSBACH MICHAEL JOSEPH was awarded 2,857 Common Stock
30-10-2026
EVP, Company Operations Suarez James Raymon was awarded 10,800 Common Stock. Suarez James Raymon holds 23,528 shares after the transaction.
- · EVP, Company Operations Suarez James Raymon was awarded 10,800 Common Stock
30-10-2026
EVP, COO LAIN JIM BRIAN was awarded 10,800 Common Stock. LAIN JIM BRIAN holds 23,788 shares after the transaction.
- · EVP, COO LAIN JIM BRIAN was awarded 10,800 Common Stock
30-10-2026
Director Smith Maurice S was awarded 17.689 Common Stock at $84.80 (~$1.5K). Smith Maurice S holds 31,989.748 shares after the transaction.
- · Director Smith Maurice S was awarded 17.689 Common Stock at $84.80 (~$1.5K)
30-10-2026
Director Martino Roxanne M was awarded 17.689 Common Stock at $84.80 (~$1.5K). Martino Roxanne M holds 67,680.963 shares after the transaction.
- · Director Martino Roxanne M was awarded 17.689 Common Stock at $84.80 (~$1.5K)
30-10-2026
Chief Operating Officer GALLAGHER JOHN R sold 431 Common Stock at $29.12 (~$12.6K). GALLAGHER JOHN R holds 32,880 shares after the transaction.
- · Chief Operating Officer GALLAGHER JOHN R sold 431 Common Stock at $29.12 (~$12.6K)
30-10-2026
President, International Goldenitsch Wolfgang had withheld for taxes 6,757 Common Stock at $0.13 (~$878). Goldenitsch Wolfgang holds 84,375 shares after the transaction.
- · President, International Goldenitsch Wolfgang exercised/converted 13,513 Common Stock
- · President, International Goldenitsch Wolfgang had withheld for taxes 6,757 Common Stock at $0.13 (~$878)
- · President, International Goldenitsch Wolfgang exercised/converted 13,513 Restricted Share Units
30-10-2026
10% owner Saba Capital Management, L.P. bought 5,975 Common Stock at $11.87 (~$70.9K). Saba Capital Management, L.P. holds 1,802,498 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 5,975 Common Stock at $11.87 (~$70.9K)
30-10-2026
Chief Financial Officer Boyce Lee A. had withheld for taxes 9,842 Common Stock at $0.13 (~$1.28K). Boyce Lee A. holds 71,510 shares after the transaction.
- · Chief Financial Officer Boyce Lee A. exercised/converted 21,234 Common Stock
- · Chief Financial Officer Boyce Lee A. had withheld for taxes 9,842 Common Stock at $0.13 (~$1.28K)
- · Chief Financial Officer Boyce Lee A. exercised/converted 21,234 Restricted Share Units
30-10-2026
Chief Financial Officer Zupfer Kersten Delores was awarded 10,800 Common Stock. Zupfer Kersten Delores holds 25,382 shares after the transaction.
- · Chief Financial Officer Zupfer Kersten Delores was awarded 10,800 Common Stock
30-10-2026
Director Charters William was awarded 2,857 Common Stock. Charters William holds 58,488 shares after the transaction.
- · Director Charters William was awarded 2,857 Common Stock
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Insider Trading Pulse
🇺🇸 More from United States
View all →October 23, 2026
US Pre-Market SEC Filings Roundup — October 23, 2026
US Pre-Market SEC Filings Roundup
October 23, 2026
US Merger & Acquisition SEC Filings — October 23, 2026
US Merger & Acquisition SEC Filings
October 23, 2026
USA Insider Trading Pulse — October 23, 2026
USA Insider Trading Pulse
October 23, 2026
US Corporate Board Director Changes SEC Filings — October 23, 2026
US Corporate Board Director Changes SEC Filings